Enveric Biosciences Reports New Brain Activity Data for Psychedelic-Derived Drug Candidate
New preclinical findings suggest EB-003 can alter brain activity without producing some of the adverse neurological effects observed with DMT ...
New preclinical findings suggest EB-003 can alter brain activity without producing some of the adverse neurological effects observed with DMT ...
As psychedelic-assisted therapy develops, researchers are investigating how music, visual imagery and treatment environments influence patients' experiences, and whether these ...
As psilocybin and MDMA move deeper into psychiatric research and clinical practice, the conversation is shifting from therapeutic promise towards ...
With six weeks to go until SCALE 2026, the international mental health and psychedelic medicine community is preparing to gather ...
© 2026 Psychedelics.media - A division of Dot Media Corp.
© 2026 Psychedelics.media - A division of Dot Media Corp.